Jacques-Philippe Moulinoux
About
In The Last Decade
Jacques-Philippe Moulinoux
32 papers receiving 680 citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 403
- Biochemistry 128
- Pharmacology 122
- Physiology 114
- Surgery 89
Countries citing papers authored by Jacques-Philippe Moulinoux
This map shows the geographic impact of Jacques-Philippe Moulinoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques-Philippe Moulinoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques-Philippe Moulinoux more than expected).
Fields of papers citing papers by Jacques-Philippe Moulinoux
This network shows the impact of papers produced by Jacques-Philippe Moulinoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques-Philippe Moulinoux. The network helps show where Jacques-Philippe Moulinoux may publish in the future.
Co-authorship network of co-authors of Jacques-Philippe Moulinoux
This figure shows the co-authorship network connecting the top 25 collaborators of Jacques-Philippe Moulinoux. A scholar is included among the top collaborators of Jacques-Philippe Moulinoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques-Philippe Moulinoux. Jacques-Philippe Moulinoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 37 | |
| 3 | Cipolla BG, Havouis R, Moulinoux JPPolyamine reduced diet (PRD) nutrition therapy in hormone refractory prostate cancer patients. Biomed Pharmacother 64(5): 363-368 | 3 |
| 4 | 6 | |
| 5 | 11 | |
| 6 | 14 | |
| 7 | 5 | |
| 8 | 35 | |
| 9 | 26 | |
| 10 | 13 | |
| 11 | 37 | |
| 12 | 20 | |
| 13 | 20 | |
| 14 | 34 | |
| 15 | 7 | |
| 16 | 57 | |
| 17 | 45 | |
| 18 | 27 | |
| 19 | 8 | |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.